Stock CLS B CLINICAL LASERTHERMIA SYSTEMS AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Clinical Laserthermia Systems AB

Equities

CLS B

SE0022049920

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
5.997 SEK +1.64% Intraday chart for Clinical Laserthermia Systems AB +3.40% -78.27%
06-25 Clinical Laserthermia Systems Signs Italian Distribution Deal for Laser Ablation Therapy MT
06-25 Clinical Laserthermia Systems AB Enters into an Exclusive Distribution Agreement with Tecnogamma S.r.l CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2024 fiscal year.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CLINICAL LASERTHERMIA SYSTEMS AB Stock Clinical Laserthermia Systems AB
-78.27% 4.41M -
EL.EN. S.P.A. Stock EL.En. S.p.A.
-5.33% 804M
B+
SISRAM MEDICAL LTD Stock Sisram Medical Ltd
-30.80% 216M -
LAMEDITECH CO., LTD. Stock LAMEDITECH Co., Ltd.
0.00% 119M - -
LASEROPTEK CO., LTD. Stock Laseroptek Co., Ltd.
-25.07% 72.07M - -
MODULIGHT OYJ Stock Modulight Oyj
-0.34% 55.58M -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CLS B Stock
  4. Ratings Clinical Laserthermia Systems AB